Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2001
10/25/2001WO2001078575A2 Ext2 as a predictive marker for osteoporosis
10/25/2001WO2001078504A2 Novel warming method of cryopreserved specimens
10/25/2001WO2001078503A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
10/25/2001WO2001044246A8 Bicyclic inhibitors of glycogen synthase kinase 3
10/25/2001WO2001027159A3 Polypeptides for detection and elimination of ca19-9 antigen positive cells
10/25/2001WO2001026679A3 T-cells and molecules involved in immune regulation
10/25/2001WO2001023597A3 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus
10/25/2001WO2001023570A3 Methods and compositions relating to sodium channel beta-1a subunits
10/25/2001WO2001023421A3 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
10/25/2001WO2001021220A3 Bioprosthetic heart valves
10/25/2001WO2001012790A3 Isomerase proteins
10/25/2001WO2001012663A3 Hematopoietic regulatory factors and methods of use thereof
10/25/2001WO2001000805A3 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
10/25/2001WO2000047618A9 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES
10/25/2001WO2000011169A3 Human cell signaling proteins (csig)
10/25/2001US20010034888 Transforming plants with nucleic acid constructs encoding sense-strand untranslatable rna molecules and/or double stranded rna molecules, rna molecules that are similar to (not identical to) certain agrobacterium tumor-inducing genes
10/25/2001US20010034887 Transformation of guar
10/25/2001US20010034884 Abeta-peptide screening assay
10/25/2001US20010034440 Complexing the target cell with therapeutic agent; antiproliferative agent
10/25/2001US20010034436 Polynucleotide and polypeptides, screening for antibiotic activity, Staphylococcus
10/25/2001US20010034337 Antiproliferative agents
10/25/2001US20010034334 Genetic engineered polypeptide
10/25/2001US20010034331 Isolated polypeptide
10/25/2001US20010034061 Culturing a population of mammalian cells capable of forming a solid tissue in a medium with oxygen level selected to enhance survival of the stem or progenitor cell type; subatmospheric oxygen; drug screening
10/25/2001US20010034060 Culture contains a nitric oxide inhibitor such as free hemoglobin
10/25/2001US20010034058 Culture device and method
10/25/2001US20010034044 Genomic sequences for protein production and delivery
10/25/2001US20010034042 Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents
10/25/2001US20010034026 Ex vivo generation of functional leukemia cells in a three-dimensional bioreactor
10/25/2001US20010034024 Mutations in and genomic structure of HERG - a long QT syndrome gene
10/25/2001US20010034022 Providing a sample suspected of containing enterovirus and a mixed cell culture comprising Rhabdomyosarcoma cells and human mucoepidermoid cells, inoculating mixed cell culture with sample, observing inoculated culture for enterovirus
10/25/2001US20010033836 Transgenic autologous T-cell therapy in humans, and related compositions and kits
10/25/2001US20010033835 Hematopoietic cell culture nutrient supplement
10/25/2001US20010033834 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
10/25/2001DE10020125A1 Agent for stimulating bone regrowth, useful as insert after surgery for bone cancer, comprises single sequence expressing a fusion of growth factor and protease inhibitor
10/25/2001DE10019195A1 Gene complex for reversible cell immortalization, useful for expanding cells for cell replacement therapy of e.g. neurodegenerative disease, contains removable immortalizing gene
10/25/2001DE10016846A1 New cell constructs from activated T-cells of patients useful as a medicament
10/25/2001CA2747325A1 Albumin fusion proteins
10/25/2001CA2406955A1 Sheep lice, bovicola ovis, allergen treatment
10/25/2001CA2406590A1 Agent for postoperative use after the removal of bone tumours
10/25/2001CA2406481A1 Trp8, a transient receptor potential channel expressed in taste receptor cells
10/25/2001CA2406245A1 Il-174 uses, compositions and methods
10/25/2001CA2406213A1 Compositions and methods for the therapy and diagnosis of breast cancer
10/25/2001CA2406196A1 Therapeutic uses for mesenchymal stromal cells
10/25/2001CA2406195A1 Lipid binding protein 4
10/25/2001CA2406192A1 Therapeutic compounds and methods for formulating v3, a versican isoform
10/25/2001CA2406180A1 Viruses comprising mutant ion channel protein
10/25/2001CA2406171A1 Reversible immortalization of cells
10/25/2001CA2406087A1 New lipid binding protein 2
10/25/2001CA2406066A1 Lipid binding protein 3
10/25/2001CA2405781A1 Secreted proteins
10/25/2001CA2405753A1 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
10/25/2001CA2405709A1 Albumin fusion proteins
10/25/2001CA2405701A1 Albumin fusion proteins
10/25/2001CA2405563A1 Albumin fusion proteins
10/25/2001CA2405557A1 Albumin fusion proteins
10/25/2001CA2405555A1 Pluripotent cells comprising allogenic nucleus and mitochondria
10/25/2001CA2405550A1 Albumin fusion proteins
10/25/2001CA2405525A1 Albumin fusion proteins
10/25/2001CA2405451A1 Molecules associated with human reproduction
10/25/2001CA2405440A1 Compositions and methods for induction of proteins involved in xenobiotic metabolism
10/25/2001CA2405404A1 Novel warming method of cryopreserved specimens
10/25/2001CA2404129A1 Codon optimisation for expression in retrovirus packaging cells
10/25/2001CA2404127A1 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
10/25/2001CA2403644A1 Drug metabolizing enzymes
10/25/2001CA2403547A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
10/25/2001CA2403508A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
10/25/2001CA2376882A1 Novel recombinant antibody, amino acid sequences of its complementarity determining regions and genes encoding the same
10/25/2001CA2370572A1 Kv10.1, a novel voltage-gated potassium channel from human brain
10/24/2001EP1148125A1 Human nucleoprotein having www domain and polynucleotide encoding the same
10/24/2001EP1147777A1 Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
10/24/2001EP1147231A1 Silent inducible virus replicons and uses thereof
10/24/2001EP1147213A2 Novel rgs-containing molecules and uses thereof
10/24/2001EP1147209A2 Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site
10/24/2001EP1147203A1 Mammalian serine racemase
10/24/2001EP1147201A2 Metalloproteinase-disintegrin family members: svph dnas and polypeptides
10/24/2001EP1147198A1 Pyruvate carboxylase from corynebacterium glutamicum
10/24/2001EP1147197A2 Schizochytrium pks genes
10/24/2001EP1147196A1 Polymorphic loci that differentiate escherichia coli 0157:h7 from other strains
10/24/2001EP1147195A1 Candida albicans srb-7
10/24/2001EP1147193A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof
10/24/2001EP1147191A1 Transcriptional regulation of the human beta3-adrenergic receptor gene
10/24/2001EP1147190A1 Her-2/neu fusion proteins
10/24/2001EP1147186A1 In vitro activated gamma delta lymphocytes
10/24/2001EP1147179A2 Human liver progenitors
10/24/2001EP1147178A1 Production of biomedical peptides and proteins in plants using transcomplementation systems
10/24/2001EP1147176A1 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
10/24/2001EP1147175A2 Fibres for culturing eukaryotic cells
10/24/2001EP1147174A1 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
10/24/2001EP1147136A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
10/24/2001EP1147134A1 Novel potassium channels and genes encoding these potassium channels
10/24/2001EP1147133A2 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules
10/24/2001EP1147123A2 Novel odorant receptors in drosophila
10/24/2001EP1147122A2 Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants
10/24/2001EP1146869A2 Inhibition of stat3 signal transduction for human cancer therapy
10/24/2001EP1146837A1 System and sequential culture media for in vitro fertilization
10/24/2001EP0791077A4 Methods for modulating transcription from the amyloid beta-protein precursor (app) promoter
10/24/2001EP0738332B1 Indicator cell line and method for detecting rna viruses
10/24/2001EP0618802B1 Synthetic compounds and compositions with enhanced cell binding
10/24/2001CN1319139A Polynucleotide constructs and uses thereof